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Abstract 
Background: Hydroxycinnamic acids (HCAs) including cinnamic acid, p‑coumaric acid, caffeic acid, and ferulic acid, 
are C6–C3 phenolic compounds that are synthesized via the phenylpropanoid pathway. HCAs serve as precursors 
for the synthesis of lignins, flavonoids, anthocyanins, stilbenes and other phenolic compounds. HCAs can also be 
conjugated with diverse compounds including quinic acid, hydroxyl acids, and amines. Hydroxycinnamoyl (HC) amine 
conjugates such as N‑HC tyramines and N‑HC phenethylamines have been considered as potential starting materials 
to develop antiviral and anticancer drugs.
Results: We synthesized N‑HC tyramines and N‑HC phenethylamines using three different approaches in Escherichia 
coli. Five N‑HC phenethylamines and eight N‑HC tyramines were synthesized by feeding HCAs and phenethylamine or 
tyramine to E. coli harboring 4CL (encoding 4‑coumarate CoA:ligase) and either SHT (encoding phenethylamine N‑HC 
transferase) or THT (encoding tyramine N‑HC transferase). Also, N‑(p‑coumaroyl) phenethylamine and N‑(p‑coumaroyl) 
tyramine were synthesized from p‑coumaric acid using E. coli harboring an additional gene, PDC (encoding phenyla‑
lanine decarboxylase) or TDC (encoding tyrosine decarboxylase). Finally, we synthesized N‑(p‑coumaroyl) phenethyl‑
amine and N‑(p‑coumaroyl) tyramine from glucose by reconstructing the metabolic pathways for their synthesis in E. 
coli. Productivity was maximized by optimizing the cell concentration and incubation temperature.
Conclusions: We reconstructed the metabolic pathways for synthesis of N‑HC tyramines and N‑HC phenethylamines 
by expressing several genes including 4CL, TST or SHT, PDC or TDC, and TAL (encoding tyrosine ammonia lyase) and 
engineering the shikimate metabolic pathway to increase endogenous tyrosine concentration in E. coli. Approxi‑
mately 101.9 mg/L N‑(p‑coumaroyl) phenethylamine and 495.4 mg/L N‑(p‑coumaroyl) tyramine were synthesized 
from p‑coumaric acid. Furthermore, 152.5 mg/L N‑(p‑coumaroyl) phenethylamine and 94.7 mg/L N‑(p‑coumaroyl) 
tyramine were synthesized from glucose.
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Background
Plants synthesize phenolic compounds through the 
phenylpropanoid pathway. Hydroxycinnamic acids 
(HCAs) serve as precursors for the synthesis of lignins, 
flavonoids, anthocyanins, stilbenes and other phe-
nolic compounds [1]. Hydroxycinnamates can be con-
jugated with diverse compounds. In the formation of 
hydroxycinnamate conjugates, hydroxycinnamates such 
as cinnamic acid, p-coumaric acid, caffeic acid, and fer-
ulic acid can serve as donors, while diverse chemicals 
including quinic acid, hydroxyl acids (maleic acid and 
tartaric acid), amino compounds (aromatic amino acids, 
choline, and anthranilic acids), and polysaccharides 
(glycerol, anthocyanin glycosides, flavonoid glycosides, 
and terpene glycosides) can be used as acceptors [2].
Hydroxycinnamoyl (HC) amides are an example 
of hydroxycinnamate conjugates, in which tyramine, 
phenethylamine, serotonin, anthranilate, tryptamine, or 
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dopamine serve as HC acceptors. HC amides are formed 
in plants for defense against pathogens [3]. For example, 
N-cinnamoyl phenylethylamine was reported to show 
antifungal activity [4]. Accumulation of N-cinnamoyl 
tyramine and N-feruloyl tyramine in tomato (Lycopersi-
con eseulentum) was found to lead to resistance against 
Pseudomonas syringae [5]. Also, some plants synthesize 
N-HC phenethylamine and N-HC tyramine. N-(p-Cou-
maroyl) tyramine and N-feruoyl tyramine are found in 
tomato [6], Solanum melongena [7], and Caspicum ann-
uum [8]. N-(p-Coumaoyl) phenethylamine has been iso-
lated from Anomianthus dulcis [9].
Many plant metabolites have been used as starting 
molecules to develop new medicines [10, 11]. HC amides 
were originally known as antioxidants, like other plant 
phenolic compounds. However, recent studies have 
shown that HC amides could be developed into new 
candidate medicines. For example, hydroxycinnamate 
amide served as a backbone for the synthesis of antiviral 
compounds [12]. Analogs of N-HC phenalkylamides are 
inhibitors of tyrosinase in human melanocytes, which 
has the potential to treat pigmentation-related disorders 
[13]. N-HC tyramine showed anti-proliferative effects on 
cancer cells [14] and selectively induced the apoptosis of 
cancer cells [15].
For the synthesis of N-HC phenethylamines and N-HC 
tyramines, the two amino acids phenylalanine and tyros-
ine, respectively, serve as the key substrates. Phenethyl-
amine and tyramine are synthesized from phenylalanine 
and tyrosine by phenylalanine decarboxylase (PDC) 
and tyrosine decarboxylase (TDC), respectively. PDC 
has been isolated and characterized from tomato [16] 
and TDC has been isolated from several plants includ-
ing parsley, Papaver somniferum, Arabidopsis thaliana, 
and Catharanthus roseus [17–21]. PDC and TDC show 
catalytic activity for both phenylalanine and tyrosine as 
substrates, but have been named depending on their sub-
strate preference. On the other hand, hydroxycinnamic 
acids are also synthesized from these two amino acids by 
phenylalanine ammonia lyase (PAL) and tyrosine ammo-
nia lyase (TAL) via the phenylpropanoid pathway [22]. 
Therefore, the endogenous concentrations of tyrosine 
and phenylalanine are critical factors for the synthesis of 
N-HC tyramines and N-HC phenethylamines in Escheri-
chia coli.
The formation of conjugates between HCs and 
phenethylamine or tyramine can be mediated by HC 
transferases (HCTs). HCTs use HC-CoA as the HC donor 
and various compounds including phenethylamine and 
tyramine as HC acceptors [23]. HC-CoA: tyramine N-
(HC) transferase (THT) catalyzes the formation of N-HC 
tyramines; the corresponding gene has been cloned from 
Capsicum annuum [24]. HC-CoA:serotonin N-(HC) 
transferase (SHT) from C. annuum was shown to cata-
lyze the formation of N-HC phenethylamines although 
it demonstrated higher affinity for serotonin than for 
phenethylamine [25]. Using these genes, it was pos-
sible to reconstruct the pathways for the synthesis of 
N-(p-coumaroyl) phenethylamine and N-(p-coumaroyl) 
tyramine in E. coli (Fig. 1).
In this report, we synthesized N-HC tyramines and 
N-HC phenethylamines from tyrosine and phenylala-
nine using metabolically engineered E. coli. The shiki-
mate pathway of E. coli which leads to the production 
of phenylalanine, tyrosine, and tryptophan, is well-
characterized and strategies to increase the intracellular 
concentrations of tyrosine and phenylalanine are also 
known. [26]. Using engineered E. coli strains, we were 
able to synthesize N-HC phenylethylamines and N-HC 
tyramines from glucose as well as from HCs.
Results
Production of N‑HC phenethylamines and N‑HC tyramines 
in E. coli
N-HC phenethylamines and N-HC tyramines were syn-
thesized from HC and phenethylamine or tyramine. Two 
enzymatic reactions were required for the synthesis of 
these compounds. The first reaction was activation of 
HCA by attaching CoA to HCA to form HC-CoA, which 
is catalyzed by 4-coumarate CoA:ligase (4CL), and the 
second reaction was formation of the conjugate between 
HC-CoA and tyramine or phenethylamine, which is 
mediated by HCT. We cloned two genes, 4CL from 
Oryza sativa and SHT from C. annuum, into an E. coli 
expression vector for the synthesis of N-HC phenethyl-
amine. The resulting E. coli strain was named HP-1. For 
the synthesis of N-HC tyramines, we used strain HT-1, 
which expresses 4CL from O. sativa and THT from C. 
annuum. The formation of the reaction products after 
feeding strain HP-1 or strain HT-1 with p-coumaric 
acid and phenethylamine or tyramine is shown in Fig. 2. 
Peaks of UV absorbance (P1 in Fig. 2a and P2 in Fig. 2b) 
obtained by high-pressure liquid chromatography 
(HPLC) were confirmed as N-(p-coumaroyl) pheneth-
ylamine and N-(p-coumaroyl) tyramine by mass spec-
trometry (data not shown). In addition, the structures of 
N-(p-coumaroyl) phenethylamine and N-(p-coumaroyl) 
tyramine were determined using nuclear magnetic 
resonance spectroscopy (NMR) (see “Methods”). We 
also observed the formation of a small amount of N-(p-
coumaroyl) tyramine (peak at 7.8  min in Fig.  2a) dur-
ing the formation of N-(p-coumaroyl) phenethylamine. 
Formation of N-(p-coumaroyl) phenethylamine was 
also observed during the synthesis of N-(p-coumaroyl) 
tyramine (peak at 10.1  min in Fig.  2b). An explanation 
for this is that yeast extract used in the growth medium 
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contained phenethylamine and tyramine which might 
have served as substrates.
Twelve HCAs were tested to determine the substrate 
range of 4CL, SHT and THT using E. coli strains HP-1 
and HT-1 (Table  1). Each HCA was fed to HP-1 along 
with phenethylamine. The strain HP-1 produced reac-
tion products with five of HCs. Among them, 3-methoxy 
cinnamic acid was the best substrate, followed by caffeic 
acid, cinnamic acid, p-coumaric acid, and ferulic acid. For 
the formation of N-HC tyramines, strain HT-1 was used. 
Eight of twelve HCAs formed conjugates with tyramine. 
Again, 3-methoxy cinnamic acid was the best substrate, 
followed by ferulic acid, m-coumaric acid, cinnamic 
acid, caffeic acid, o-coumaric acid, p-coumaric acid, and 
4-methoxy-cinnamic acid (Table 2). Among five naturally 
occurring HCAs (cinnamic acid, p-coumaric acid, caf-
feic acid, ferulic acid, and sinapic acid), all of them except 
sinapic acid led to the formation of either N-HC pheneth-
ylamines or N-HC tyramines. These results indicate that 
the size of each HC was a determining factor in whether 
they could act as substrates for the formation of the cor-
responding N-HC phenethylamines or N-HC tyramines. 
When cinnamic acids containing more than two methoxy 
groups were used as substrates, neither N-HC phenethyl-
amines nor N-HC tyramines were formed.
Synthesis of N‑(p‑coumaroyl) phenethylamine in E. coli
Among the several reaction products, we decided to 
synthesize N-(p-coumaroyl) phenethylamine and N-(p-
coumaroyl) tyramine by feeding E. coli with only p-cou-
maric acid. For this, either a decarboxylase that can 
convert phenylalanine into phenethylamine or one that 
can convert tyrosine into tyramine was introduced into 
Fig. 1 A schematic pathway for the synthesis of N‑(p‑coumaroyl) phenethylamine and N‑(p‑coumaroyl) tyramine in Escherichia coli. ppsA phos‑
phoenolpyruvate synthetase, tktA transketolase, tyrR phenylalanine DNA‑binding transcription repressor, aroG deoxyphosphoheptonate aldolase, 
tyrA prephenate dehydrogenase, pheA prephenate dehydratase, tyrB phenylalanine aminotransferase, TAL tyrosine amino lyase, 4CL 4‑coumaroyl‑
CoA ligase, TDC tyrosine decarboxylase, PDC phenylalanine decarboxylase, THT tyramine N‑hydroxycinnamoyl transferase, SHT phenethylamine 
N‑hydroxycinnamoyl transferase. Tyrosine inhibits tyrR and tyrA while phenylalanine inhibits pheA. PDC, TDC, TAL, SHT, and THT were introduced into 
E. coli to synthesize N‑(p‑coumaroyl) phenethylamine and N‑(p‑coumaroyl) tyramine









































































Fig. 2 HPLC analysis of N‑(p‑coumaroyl) phenethylamine (a) and 
N‑(p‑coumaroyl) tyramine (b). P1 and P2 indicate the reaction prod‑
ucts. The inset shows the mass spectra of the reaction products. The 
peak detected at 6.5 min in Fig. 1b is a p‑coumaric acid
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the E. coli strains HP-1 and HT-1. We engineered strain 
HP-2 to synthesize N-(p-coumaroyl) phenethylamine by 
transforming E. coli with PDC along with SHT and 4CL 
and then feeding them p-coumaric acid. Analysis of the 
cultures from strain HP-2 using HPLC showed a peak 
with the same retention time as that of N-(p-coumaroyl) 
phenethylamine and its structure as that compound was 
confirmed by MS and NMR (data not shown). There-
fore, we decided to use the HP-2 strain for optimization 
of the production of N-(p-coumaroyl) phenethylamine. 
First, we tested the effect of initial cell density. The cell 
density of HP-2 was adjusted to an OD600 of 1, 3, 5, or 
7. The production of N-(p-coumaroyl) phenethylamine 
increased from 22.8  mg/L at OD600  =  1, 55.7  mg/L at 
OD600 = 3, and 59.6 mg/L at OD600 = 5, but decreased 
to 51.6  mg/L at OD600  =  7. The optimal incubation 
temperature was determined at the optimized cell 
density of OD600  =  5. HP-2 grown at 25, 30, or 37  °C 
produced 43.1, 59.6, or 48.2  mg/L N-(p-coumaroyl) 
phenethylamine, respectively. The initial p-coumaric 
acid concentration was then optimized with the opti-
mized cell density (OD600 = 5) and incubation tempera-
ture (30  °C). The strain HP-2 was fed with 0.2, 0.4, 0.6, 
0.8, or 1.0 mM of p-coumaric acid and the production of 
N-(p-coumaroyl) phenethylamine was examined. HP-2 
converted 81.8 % of 0.2 mM p-coumaric acid into N-(p-
coumaroyl) phenethylamine, producing 43.7 mg/L N-(p-
coumaroyl) phenethylamine. When the cells were fed 
with 0.4  mM p-coumaric acid, the conversion rate was 
80.4 %, producing 85.9 mg/L N-(p-coumaroyl) pheneth-
ylamine. At higher p-coumaric acid concentrations, the 
conversion rate of p-coumaric acid was less than 50  % 
Table 1 Plasmids and strains used in the present study
Plasmids or E. coli strain Relevant properties or genetic marker(s) Source or references
Plasmids
 pACYCDuet P15A ori, Cmr Novagen
 pCDFDuet CloDE13 ori, Strr Novagen
 pETDuet f1 ori, Ampr Novagen
 pA‑SeTAL pACYCDuet carrying TAL from Saccharothrix espanaensis [31]
 pA‑aroG‑SeTAL‑tyrA pACYCDuet carrying TAL from S. espanaensis, aroG and tyrA from Escherichia coli [31]
 pA‑aorGfbr‑SeTAL‑tyrAfbr pACYCDuet carrying TAL from S. espanaensis, aroGfbr, and tyrAfbr from E. coli
 pE‑PDC pETDuet carrying PDC from Pseudomonas putida
 pC‑Os4CL‑SHT pCDFDuet carrying 4CL from Oryza sativa and SHT from Capsicum annuum
 pC‑Os4CL‑THT pCDFDuet carrying 4CL from O. sativa and THT from C. annuum This study
 pC‑TDC‑Os4CL‑THT pCDFDuet carrying TDC from Papaver somniferum, 4CL from O. sativa, and THT from C. annuum This study
Strains
 BL21 (DE3) F− ompT hsdSB(rB
− mB
−) gal dcm lon (DE3) Novagen
 BtyrR BL21(DE3) ΔtyrR [31]
 BtyrR‑trpD BL21(DE3) ΔtyrR/ΔtrpD This study
 HP‑1 BL21 harboring pC‑Os4CL‑SHT This study
 HP‑2 BL21 harboring pC‑Os4CL‑SHT and pE‑PDC This study
 HP‑3 BL21 harboring pC‑Os4CL‑SHT, pA‑SeTAL, and pE‑PDC This study
 HP‑4 BL21 harboring pC‑Os4CL‑SHT, pA‑aroG‑SeTAL‑tyrA, and pE‑PDC This study
 HP‑5 BL21 harboring pC‑Os4CL‑SHT, pA‑aroGfbr‑SeTAL‑tyrAfbr, and pE‑PDC This study
 HP‑6 BtyrR harboring pC‑Os4CL‑SHT, pA‑aroGfbr‑SeTAL‑tyrAfbr, and pE‑PDC This study
 HP‑7 BtyrR‑trpD harboring pC‑Os4CL‑SHT, pA‑aroGfbr‑SeTAL‑tyrAfbr, and pE‑PDC This study
 HT‑1 BL21 harboring pC‑Os4CL‑THT This study
 HT‑2 BL21 harboring pC‑TDC‑Os4CL‑THT This study
 HT‑3 BL21 harboring pC‑TDC‑Os4CL‑THT and pA‑aroG‑tyrA This study
 HT‑4 BL21 harboring pC‑TDC‑Os4CL‑THT and pA‑aroGfbr‑tyrAfbr This study
 HT‑5 BL21 harboring pC‑TDC‑Os4CL‑THT and pA‑SeTAL This study
 HT‑6 BL21 harboring pC‑TDC‑Os4CL‑THT and pA‑aroG‑SeTAL‑tyrA This study
 HT‑7 BL21 harboring pC‑TDC‑Os4CL‑THT and pA‑aroGfbr‑SeTAL‑tyrAfbr This study
 HT‑8 BtyrR‑pheA harboring pC‑TDC‑Os4CL‑THT and pA‑aroGfbr‑SeTAL‑tyrAfbr This study
 HT‑9 BtyrR‑trpD harboring pC‑TDC‑Os4CL‑THT and pA‑aroGfbr‑SeTAL‑tyrAfbr This study
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and the final yields of N-(p-coumaroyl) phenethylamine 
were 78.5, 74.0 and 59.6 mg/L, respectively, which were 
much lower than the yield at 0.4  mM p-coumaric acid. 
Using the optimized initial concentration of p-coumaric 
acid (0.4  mM), we monitored the production of N-(p-
coumaroyl) phenethylamine and found that approxi-
mately 101.9  mg/L N-(p-coumaroyl) phenethylamine 
was produced after 12 h, after which the yield decreased 
until 24  h (data not shown). Approximately 95.3  % of 
p-coumaric acid was converted into N-(p-coumaroyl) 
phenethylamine.
N-(p-Coumaroyl) phenethylamine is a conjugate of 
p-coumaric acid and phenethylamine. p-Coumaric 
acid is synthesized from tyrosine by TAL and pheneth-
ylamine is synthesized from phenylalanine by PDC. 
Therefore, the intracellular concentrations of both tyros-
ine and phenylalanine are critical for the final yield of 
N-(p-coumaroyl) phenethylamine. Tyrosine and pheny-
lalanine are synthesized through the shikimate pathway. 
Two genes, aroG and tyrA, were overexpressed in order 
to increase the amount of tyrosine and phenylalanine. 
The gene aroG, which encodes 2-dehydro-3-deoxyphos-
phoheptonate aldolase, catalyzes the first reaction in 
the shikimate pathway. The gene tyrA, which encodes 
chorismate mutase/prephenate dehydrogenase, uses 
chorismate to make prephenate, which is used for the 
synthesis of phenylalanine and tyrosine. Both the AroG 
and TyrA proteins are inhibited by their final products 
(phenylalanine and tyrosine, repectively). Therefore, the 
feed back inhibition-free versions of aroG  (aroGfbr) and 
tyrA (tyrA fbr) were used [27]. The production of N-(p-
coumaroyl) phenethylamine was examined in three E. 
coli strains (HP-3, HP-4, and HP-5). HP-5 produced the 
highest amount of N-(p-coumaroyl) phenethylamine at 
approximately 46.1 mg/L, followed by HP-4 (29.6 mg/L), 
and HP-3 (14.6  mg/L) (Fig.  3a). Therefore, the tyrosine 
concentration in E. coli was directly related to the yield 
of N-(p-coumaroyl) phenethylamine. Next, we tested 
different E. coli mutants, which are expected to increase 
the production of tyrosine. The tyrR deletion mutant 
was the first mutant strain. TyrR is a transcription factor 
that is inhibited by tyrosine and phenylalanine. Deletion 
of trpD, which encodes the enzyme for the synthesis of 
tryptophan from chorismate, can result in higher sub-
strate availability for the production of both tyros-
ine and phenylalanine. Therefore, two mutant strains, 







p-Coumaric acid 36 52
m-Coumaric acid 0 86
o-Coumaric acid 0 66
Caffeic acid 43 66
Ferulic acid 35 92





1 3,4-dimethoxycinnamic acid, 2,4-dimethoxycinnamic acid, sinapic acid, and 3,4,5-trimethoxycinnamic acid were tested but did not serve as substrates for either 
enzyme
2 Relative activity was calculated by denoting the activity of the best substrate as 100 %
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B-tryR (HP-6) and B-tyrR-typD (HP-7), both of which 
were transformed with the genes for N-(p-coumaroyl) 
phenethylamine, were used to examine the production of 
N-(p-coumaroyl) phenethylamine. Strain HP-7 produced 
104.6  mg/L N-(p-coumaroyl) phenethylamine and HP-6 
produced 92.9 mg/L (Fig. 3b). This result indicated that 
the final yield of N-(p-coumaroyl phenethylamine) was 
increased when more precursors for both tyrosine and 
phenylalanine are available.
Using the strain HP-7, the incubation temperature 
and the initial cell density were optimized. HP-7 was 
grown at18, 25, or 30  °C. The highest production of 
N-(p-coumaroyl) phenethylamine occurred in cells 
grown at 25  °C (106.1 mg/L), while the yields at 18 and 
30  °C were approximately 90.8 and 88.5  mg/L, respec-
tively. The optimal initial cell density was also exam-
ined. The cell density of HP-7 was adjusted with the 
culture medium to OD600 =  0.5, 1, or 1.5, and the pro-
duction of N-(p-coumaroyl) phenethylamine was exam-
ined at the optimized temperature of 25 °C. The yield of 
N-(p-coumaroyl) phenethylamine was decreased from 
136.1  mg/L at OD600 =  0.5, 106.1  mg/L at OD600 =  1.0 
and 91.0 mg/L at OD600 = 1.5. Using the optimized incu-
bation temperature and cell density of strain HP-7, the 
production of N-(p-coumaroyl) phenethylamine was 
monitored for 36 h. The production of N-(p-coumaroyl) 
phenethylamine was observed at 6  h and continued to 
increase until 15  h, when production was maximized. 
The yield of N-(p-coumaroyl) phenethylamine at 15  h 
was 152.5  mg/L. After 15  h, production was decreased 
(Fig. 4).
Synthesis of N‑(p‑coumaroyl) tyramine in E. coli
In order to synthesize N-(p-coumaroyl) tyramine by feed-
ing with p-coumaric acid, an additional gene, TDC was 
introduced into HT-1. The resulting strain HT-2 was fed 
with p-coumaric acid and analysis of the reaction prod-
ucts using HPLC showed that N-(p-coumaroyl) tyramine 
was synthesized (data not shown). We also tested the 
optimal initial concentration of p-coumaric acid and 
found that the production of N-(p-coumaroyl) tyramine 
was increased up to 2.5 mM p-coumaric acid. Next, we 
tested the effect of tyrosine on the production of N-(p-
coumaroyl) tyramine. Although p-coumaric acid was 
externally supplied to E. coli, tyramine needed to be syn-
thesized from tyrosine. The strain HT-4, containing the 
feedback-inhibition free versions of aroG and tyrA (aroG 
fbr and tyrA fbr) produced approximately 80.0 mg/L N-(p-
coumaroyl) tyramine, which is more than was produced 
by strains HT-2 (48.2 mg/L) and HT-3 (58.9 mg/L). Using 
strain HT-4, we optimized the incubation temperature 
and initial cell concentration. The optimal incubation 
temperature and initial cell concentration were deter-
mined to be 30  °C and OD600  =  7, respectively. Using 
HT-4, approximately 495.4  mg/L N-(p-coumaroyl) 
tyramine was synthesized after 24 h of incubation, after 
which the production decreased (Fig. 5).
Next, we synthesized N-(p-coumaroyl) tyramine 
from tyrosine. For this, the intracellular concentra-
tion of tyrosine is critical. Therefore, we used the same 
strategies as used for the synthesis of N-(p-coumaroyl) 
Fig. 3 Effects of construct (a) or E. coli strain (b) on the production of 
N‑(p‑coumaroyl) phenethylamine Fig. 4 Production of N‑(p‑coumaroyl) phenethylamine using E. coli 
strain HP‑7
Fig. 5 Production of N‑(p‑coumaroyl) tyramine by feeding E. coli 
strain HT‑4 with p‑coumaric acid
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phenethylamine in order to supply more tyrosine. We 
examined the effects of different constructs and E. coli 
mutants on the production of N-(p-coumaroyl) tyramine. 
As expected, the strain HT-7 (36.0 mg/L) produced more 
tyrosine than the other strains did (HT-6, 6.3 mg/L and 
HP-5, 2.5  mg/L) (Fig.  6a). Therefore, the tyrosine con-
centration in E. coli was directly related to the yield of 
N-(p-coumaroyl) tyramine. Also, the E. coli mutant, 
BtyrR-trpD (HT-9, 57.1 mg/L) produced more N-(p-cou-
maroyl) tyramine than BtyrR-pheA (HT-8, 37.8  mg/L). 
Again, the intracellular tyrosine concentration was 
directly related to the final yield of N-(p-coumaroyl) 
tyramine (Fig. 6b).
In order to optimize the production of N-(p-cou-
maroyl) tyramine using the strain HT-9, the incubation 
temperature and initial cell density were optimized. The 
best temperature was determined to be 30 °C (57.1 mg/L) 
followed by 25  °C (52.5  mg/L), 37  °C (39.2  mg/L), and 
18 °C (22.0 mg/L).
Using the strain HT-9, the incubation temperature 
and the initial cell density were optimized. HT-9 was 
grown at 18, 25, 30, or 37 °C. The highest production of 
p-coumaroyl tyramine occurred in cells grown at 30  °C 
(57.06 mg/L). The yields at 18, 25 and 37 °C were approxi-
mately 21.98, 52.47 and 39.16  mg/L, respectively. The 
optimal initial cell density was also examined. The pro-
duction of N-(p-coumaroyl) tyramine increased from 
OD600 = 0.5 to OD600 = 2 but decreased at OD600 = 3.
The production of N-(p-coumaroyl) tyramine was 
monitored for 36 h with strain HT-9. The production of 
N-(p-coumaroyl) tyramine was observed at 3 h and con-
tinued to increase until 27 h, at which time the produc-
tion of N-(p-coumaroyl) tyramine was maximized. The 
yield of N-(p-coumaroyl) tyramine at 27 h was 94.7 mg/L. 
After 27 h, the production decreased (Fig. 7).
Discussion
Five N-HC phenethylamines and eight N-HC tyramines 
from 12 HCAs and corresponding amines (pheneth-
ylamine and tyramine) were synthesized. Two enzy-
matic reactions are required to synthesize N-HC 
phenethylamines or N-HC tyramines in E. coli. The first 
step is the activation of HC by 4CL which results in the 
formation of HC-CoA. The second step is the conjuga-
tion of HC-CoA to phenethylamine or tyramine, which 
is catalyzed by either SHT or THT. Based on the results 
of HT-1 biotransformation, Os4CL used in this study 
could use at least eight HCAs as substrates (p-coumaric 
acid, m-coumaric acid, o-coumaric acid, caffeic acid, 
ferulic acid, cinnamic acid, 3-methoxycinnamic acid, 
and 4-methoxycinnamic acid). However, HCAs having 
two methoxy groups did not yield any reaction products. 
It is not clear whether this result is due to the failure of 
Os4CL to convert HCA into HC-CoA or due to the for-
mation of conjugates between HC-CoA and tyramine 
or phenethylamine by THT or SHT. These results also 
suggested that THT, which was used for the formation 
of N-HC tyramines, had broader acyl donor specificity 
than did SHT, which was used for the synthesis of N-HC 
phenethylamines.
It is not clear whether the different rates of N-HC 
phenethylamines and N-HC tyramines formation 
observed can be attributed to the first step or the second 
step. It is, however, clear that Os4CL used p-coumaric 
acid or caffeic acid more efficiently than it used ferulic 
acid [28]. In the formation of N-HC tyramine, N-feruloyl 
tyramine was synthesized more effectively than N-(p-
coumaroyl) tyramine or N-caffeoyl tyramine. These 
observations suggest that the second reaction catalyzed 
by THT determines the rate of product formation.
We synthesized N-(p-coumaroyl) phenethylamines 
and N-(p-coumaroyl) tyramines using three different 
approaches. Firstly, HC and either phenethylamine or 
tyramine were used as substrates. Two genes, 4CL and 
either SHT for N-(p-coumaroyl) phenethylamine bio-
synthesis or THT for N-(p-coumaroyl) tyramine bio-
synthesis, were transformed into E. coli and various 

















































Fig. 6 Effect of different gene combinations (a) and E. coli strains (b) 
on the production of N‑(p‑coumaroyl) tyramine from glucose in E. coli
Fig. 7 Production of N‑(p‑coumaroyl) tyramine using E. coli strain 
HT‑9
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and either phenylalanine or tyrosine were used. For this, 
an additional gene, either PDC or TDC was introduced 
to convert phenylalanine or tyrosine into phenethyl-
amine or tyramine, respectively. Thirdly, we synthesized 
N-(p-coumaroyl) phenethylamine and N-(p-coumaroyl) 
tyramine from amino acids (phenylalanine and tyros-
ine, respectively) by introducing TAL into E. coli. In 
these approaches, the yield of the major product was 
much higher than that of byproduct(s). It is likely that 
it is related to the specificity of the enzymes employed 
in this study. During screening of HCTs using biotrans-
formation, we observed that both SHT and THT used 
both phenethylamine and tyramine (Fig.  2), although 
SHT showed a preference for phenethylamine and THT 
showed a preference for tyramine. Previous in  vitro 
kinetic data have also shown that SHT has a higher pref-
erence for phenethylamine than for tyramine [25]. This 
is one reason that only a small amount of byproduct is 
observed. Moreover, the amino acid decarboxylases (PDC 
and TDC) used in this study showed high substrate spe-
cificities. PDC from Pseudomonas putida showed higher 
substrate specificity for phenylalanine than for tyrosine 
[29] and TDC from P. somniferum showed activity for 
tyrosine but not for phenylalanine [20]. Furthermore, the 
TAL we used was previously found to show higher sub-
strate specificity for tyrosine [30] than for phenylalanine. 
Therefore, byproducts were rarely synthesized. Taken 
together, using specific enzymes for each reaction step 
contributed to the synthesis of a specific product with 
only the formation of a small amount of byproduct(s).
Conclusions
HC-amine conjugates such as N-HC tyramines and N-
HC phenethylamines have been considered as poten-
tial starting materials for development of antiviral and 
anticancer drus. We synthesized N-HC tyramines and 
N-HC phenethylamines using E. coli harboring 4CL and 
either THT or SHT. Approximately 101.9  mg/L N-(p-
coumaroyl) phenethylamine and 495.4  mg/L N-(p-cou-
maroyl) tyramine were synthesized from p-coumaric acid 
using E. coli harboring an additional gene either PDC or 
TDC. Finally, we synthesized 152.5 mg/L N-(p-coumaroyl) 
phenethylamine and 94.7 mg/L N-(p-coumaroyl) tyramine 
from glucose by engineering the shikimate pathway of E. 
coli and reconstructing the pathway toward synthesis of 
N-(p-coumaroyl) phenethylamine and N-(p-coumaroyl) 
tyramine. Productivity was further improved by optimiz-
ing the cell concentration and incubation temperature.
Methods
Constructs and E. coli strains
Os4CL was previously cloned in our lab [28] and was 
subcloned into the EcoRI/NotI sites of pCDFDuet1 
(pC-Os4CL). HC-CoA: serotonin N-(HC) transferase 
(CaSHT) from Capsicum annuum (GenBank accession 
number AF329463.1) for the synthesis of N-(p-cou-
maroyl) phenethylamine was cloned using reverse tran-
scription-polymerase chain reaction (RT-PCR). cDNA 
was isolated from the leave of C. annuum. PCR was car-
ried out using primers, 5′-ATGATATCGATGGCTTCT-
GCTCCTCAACCACCAA-3′ (EcoRV site is underlined.) 
as a forward primer and 5′-ATCTCGAGCTAACA-
GCTTCCTGCACCATTTTTCT-3′ (XhoI site is under-
lined.) as a reverse primer. The resulting PCR product 
was subcloned into the EcoRV/XhoI sites of pC-Os4CL 
and named pC-Os4CL-SHT.
PDC from P. putida (GenBank accession number 
BK006920) was amplified using PCR using genomic 
DNA as a template using 5′-ATCATATGGTGACCCC-
CGAACAATTCCGCC-3′ (NdeI site is underlined.) as a 
forward primer and 5′-AACTCGAGTCAGCCCTTGAT-
CACGTCCTGC-3′ (XhoI site is underlined.) as a reverse 
primer. The resulting PCR product was subcloned into 
the NdeI/XhoI sites of pET-Duet1 (Novagene, Madison, 
WI, USA) and the construct was named pE-PDC. TDC 
from Papaver somniferum was synthesized after codon 
optimization for E. coli based on the published sequence 
(GenBank U08598.1) and subcloned into BamHI/HindIII 
sites of pCDF. The construct formed was named pC-
TDC. Os4CL was amplified with a forward primer con-
taining T7 promoter sequence and HindIII site and a 
reverse primer containing a NotI site. The resulting PCR 
product was subcloned into the HindIII/NotI sites of pC-
TDC and the construct was named pC-TDC-Os4CL. 
Tyramine N-HC transferase (THT) from C. annuum 
(GenBank accession number AY819700.1) was cloned 
using RT-PCR. The resulting PCR product was subcloned 
into the NdeI/EcoRV sites of pC-TDC-Os4CL and the 
construct was named pC-TDC-Os4CL-THT.
pA-SeTAL, pA-aroG-SeTAL-tyrA, and pA-aroGfbr-
SeTAL-tyrAfbr were cloned previously [31].
Synthesis of N‑HC phenethylamines and N‑HC tyramines
HCAs including p-coumaric acid, m-coumaric acid, 
o-coumaric acid, caffeic acid, ferulic acid, cinnamic 
acid, 3-methoxycinnamic acid, 4-methoxycinnamic 
acid, 3,4-dimethoxycinnamic acid, 2,4-dimethoxycin-
namic acid, sinapic acid, and 3,4,5-trimethoxycinnamic 
acid were purchased from Sigma-Aldrich (St. Louis, 
MO, USA). Preference of HCA for the synthesis of N-
HC phenethylamines or N-HC tyramines was tested as 
follows. E. coli strains HP-1 and (Table  1) for the syn-
thesis of N-HC phenethylamines and N-HC tyramines, 
respectively were grown at 37 °C for 18 h in LB medium 
containing 50  μg/mL spectinomycin. The culture was 
inoculated into a fresh new LB medium containing 
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50  μg/mL spectinomycin. Cells were grown until 
OD600  =  0.8, at which point 1  mM isopropyl β-d-1-
thiogalactopyranoside (IPTG) was added, and contin-
ued to grow at 18  °C for a further 24  h. The cells were 
harvested and resuspended in M9 medium containing 
2 % (w/v) glucose, 1 % (w/v) yeast extract, either 500 μM 
HCA (for the synthesis of N-HC phenethylamines) or 
1 mM HCA (for the synthesis of HC-tyramine), 100 μg/
ml antibiotic(s), and 1  mM IPTG. Fourteen HC deriva-
tives (p-coumaric acid, m-coumaric acid, o-coumaric 
acid, caffeic acid, ferulic acid, cinnamic acid, 3-methoxy-
cinnamic acid, 4-methoxycinnamic acid, 3,4-dimethoxy-
cinnamic acid, 2,4-dimethoxycinnamic acid, sinapic acid, 
and 3,4,5-trimethoxycinnamic acid) were used, individ-
ually. The cultures were incubated at 30  °C for 3  h and 
then extracted with ethylacetate. After drying the aque-
ous layer and dissolving it in dimethylsulfoxide (DMSO), 
the product was analyzed by HPLC. The relative N-HC 
phenethylamine or N-HC tyramine formation rates were 
calculated relative to that of the best substrate, which was 
denoted as 100 %.
The metabolites were analyzed using an UltiMate 
3000 HPLC (Thermo Scientific, Waltham, MA, USA) 
equipped with a photo diode array (PDA) detector and 
a C18 reversed-phase column (4.60 ×  250  mm, 3.5 μm 
particle size, Varian, Palo Alto, CA, USA). The mobile 
phase consisted of 0.1  % (v/v) formic acid in water and 
acetonitrile. The program was as follows: 20 % (v/v) ace-
tonitrile at 0 min, 60 % at 8 min, 90 % at 12 min, 90 % at 
15 min, 20 % at 15.1 min, 20 % at 20 min. The flow rate 
was 1 ml/min and UV absorbance was monitored at 278 
and 310 nm.
Mass spectrometry (MS) was carried out as described 
previously [32]. The structures of N-(p-coumaroyl) 
phenethylamine and N-(p-coumaroyl) tyramine were 
determined using nuclear NMR [33]. The NMR data were 
as follows; N-(p-coumaroyl) phenethylamine: 1H NMR 
(400 MHz, DMSO-d6) δ 7.39 (d, J = 8.6 Hz, 2H), 7.34 (d, 
J = 15.7 Hz, 1H), 7.29 (m, 2H), 7.22 (d, J = 7.97, 2H), 7.20 
(dd, J = 16.4, 7.5 Hz, 1H), 6.80 (d, J = 8.6 Hz, 2H), 6.42 (d, 
J = 15.7 Hz, 1H), 3.41 (m, 2H), 2.78 (t, J = 3.5 Hz, 2H); 
13C NMR (100  MHz, DMSO-d6) δ 165.3, 158.8, 139.5, 
138.6, 129.2, 128.6, 128.3, 126.0, 125.9, 118.6, 115.7, 40.3, 
35.2.
N-(p-Coumaroyl) tyramine: 1H NMR (400  MHz, 
DMSO-d6) δ 8.00 (s, NH), 7.38 (m, 2H), 7.31 (d, 
J = 15.7 Hz, 1H), 7.00 (m, 2H), 6.79 (m, 2H), 6.68 (m, 2H), 
6.40 (d, J = 15.7 Hz, 1H), 3.32 (dd, J = 7.4, 6.3 Hz, 2H), 
2.64 (t, J = 7.4 Hz, 2H); 13C NMR (100 MHz, DMSO-d6) 
δ 165.3, 158.8, 155.6, 138.5, 129.5, 129.4, 129.1, 125.9, 
118.7, 115.7, 115.1, 40.6, 34.4.
N-(p-Coumaroyl) phenethylamine and N-(p-cou-
maroyl) tyramine were collected and used as standards 
for the calculation of the production of other N-HC 
phenethylamines and N-HC tyramines, respectively.
Total synthesis of N‑(p‑coumaroyl) phenethylamine 
and N‑(p‑coumaroyl) tyramine
Overnight cultures of E. coli strains, HTs or HPs (Table 1) 
were inoculated into 15  ml of fresh LB medium con-
taining appropriate antibiotics and were cultured to 
OD600  =  1. Cells were harvested by centrifugation and 
cell density was adjusted to OD600  =  2 with 10  mL of 
M9 medium containing 2  % (w/v) glucose, 1  % (w/v) 
yeast extract, 50 μg/mL antibiotics, and 1 mM IPTG in a 
100 mL flask. The cells were grown at 30 °C with shaking 
at 180  rpm for 24 h. To analyze product formation, cell 
growth was monitored by determining the absorbance at 
600  nm. Culture supernatants were collected, extracted 
twice with an equal volume of ethyl acetate, and then 
dried under vacuum. The dried samples were dissolved in 
DMSO and analyzed using HPLC.
The mean and the standard deviation (SD) were calcu-
lated from triplicate experiments. Analysis of variance 
(ANOVA) was carried out using Tukey’s method, with 
significance at a P value of 0.01, using Microsoft Excel.
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